CONTACT | CLIENT LOGIN | NEWS | IDIFARMA obtains Australian GMP Clearance February 2016 Recently, Idifarma has obtained the Australian TGA clearance for the manufacture of finished products, which allows Idifarma to manufacture products for that country. After an in-depth assessment of the quality system, experience and capacities, the TGA has submitted this approval following the procedure suitable for non-Australian overseas manufacturers. With this authorization, Idifarma keeps on going in the commitment of increasing its offer of services as CMO with international reach, adding a new country to the growing list of markets where it is already operating. Last Updated on Tuesday, 16 February 2016 12:20 © Idifarma Desarrollo Farmacéutico, S.L. - Pol Mocholi C/ Noáin, 1 - 31110 Noáin (Navarra, Spain) - Tlf +34 948 214 023 - Fax: +34 948 312 359 - info@idifarma.com COMPANY CONTRACT DEVELOPMENT CONTRACT MANUFACTURING FACILITIES TECHNOLOGICAL SOLUTIONS About us Project Management Introduction Layout Introduction History Analytical Development GMP Clinical Batches Analytical Laboratory High Containment Certification Formulation Development GMP Commercial Batches Formulation Laboratory Spray Drying Clients GMP Manufacturing GMP Pilot Plant Film Coating Quality Control Stability Studies Clinical Trial Logistics Regulatory Affairs LEGAL NOTICE | LOCATION | CONTACT FORM | CAREERS | NEWS | CLIENT LOGIN